AlphaGrep UK’s Zimmer Biomet ZBH Stock Holding History

AlphaGrep UK’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,554	Closed	-$231K	–	986
2026 Q1	$231K	Buy	+2,554	New	+$234K	0.07%	648

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AlphaGrep UK's ZBH Position: Q2 2026 in Review

AlphaGrep UK sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 2,554 shares — an estimated $231K sold.

AlphaGrep UK first reported a position in ZBH in Q1 2026 and held it in 1 quarter. The position peaked at $231K in Q1 2026. 853 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

AlphaGrep UK reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 2,554 Zimmer Biomet shares in Q2 2026, an estimated $231K.
AlphaGrep UK first reported a position in Zimmer Biomet in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Zimmer Biomet position peaked at $231K in Q1 2026.
853 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.